NCT01660568View on ClinicalTrials.gov

Gemcitabine in NK/T Cell Lymphoma

CompletedOBSERVATIONAL
Enrollment

20

Participants

Timeline

Start Date

August 31, 2012

Primary Completion Date

January 31, 2013

Study Completion Date

January 31, 2013

Conditions
NK/T Cell Lymphoma
Trial Locations (1)

Unknown

Samsung Medical Center, Seoul

All Listed Sponsors
lead

Samsung Medical Center

OTHER

NCT01660568 - Gemcitabine in NK/T Cell Lymphoma | Biotech Hunter | Biotech Hunter